Related Experiment Video
Updated: Oct 29, 2025

07:14
A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
14.7K
A portable impedance microflow cytometer for measuring cellular response to hypoxia
Darryl Dieujuste1, Yuhao Qiang1, E Du1
1Department of Ocean and Mechanical Engineering, and the Department of Biological Sciences, Florida Atlantic University, Boca Raton, Florida, USA.
Biotechnology and Bioengineering
|July 7, 2021
Summary
A new low-cost microflow cytometer analyzes single cells using electrical impedance. It effectively differentiates sickle cell disease blood samples from normal ones, showing potential for field diagnostics.
Area of Science:
- Biomedical Engineering
- Cellular Biology
- Medical Diagnostics
Background:
- Sickle cell disease (SCD) diagnosis and monitoring often require specialized laboratory equipment.
- Portable and low-cost diagnostic tools are needed for field and low-resource settings.
- Understanding cellular responses to microenvironmental changes, like oxygen levels, is crucial for disease characterization.
Purpose of the Study:
- To develop and validate a low-cost, portable electrical impedance-based microflow cytometer for single-cell analysis.
- To assess the system's capability in differentiating sickle cell disease blood samples from normal samples.
- To investigate cellular electrical property changes in response to controlled oxygen microenvironments.
Main Methods:
- Development of a microflow cytometer integrating an impedance analyzer chip, microfluidic chip, and microcontroller.
- Utilizing a custom Android application for system operation and data acquisition.
- Conducting case studies on human red blood cells (RBCs) from normal and sickle cell disease patients under varying oxygen conditions.
Main Results:
- The microflow cytometer successfully identified distinct impedance patterns for sickle cell disease blood samples compared to normal samples.
- A conformity score effectively quantified intrapatient and interpatient variations in SCD.
- Hypoxia treatment induced significant changes in RBC cytoplasmic resistance and membrane capacitance, with SCD cells showing a more pronounced response.
Conclusions:
- The developed low-cost microflow cytometer demonstrates potential as a screening technique for sickle cell disease in resource-limited settings.
- The system can differentiate between normal and sickle cell blood based on impedance measurements under varying oxygen levels.
- The methodology offers a platform for analyzing cellular responses to hypoxia in various cell types.

